The impact of biologic response modifiers on hepatitis B virus infection.
about
Hepatitis B virus reactivation associated with antirheumatic therapy: Risk and prophylaxis recommendationsConsensus statement on blocking the effects of interleukin-6 and in particular by interleukin-6 receptor inhibition in rheumatoid arthritis and other inflammatory conditions.Evaluation and management of hepatitis B virus infection in hematopoietic stem cell transplantation: before and after transplantation.Subcutaneous formulation of tocilizumab for treatment of rheumatoid arthritis.Safety of Abatacept in Rheumatoid Arthritis With Serologic Evidence of Past or Present Hepatitis B Virus Infection.
P2860
The impact of biologic response modifiers on hepatitis B virus infection.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The impact of biologic response modifiers on hepatitis B virus infection.
@en
The impact of biologic response modifiers on hepatitis B virus infection.
@nl
type
label
The impact of biologic response modifiers on hepatitis B virus infection.
@en
The impact of biologic response modifiers on hepatitis B virus infection.
@nl
prefLabel
The impact of biologic response modifiers on hepatitis B virus infection.
@en
The impact of biologic response modifiers on hepatitis B virus infection.
@nl
P2860
P1476
The impact of biologic response modifiers on hepatitis B virus infection.
@en
P2093
Matthew B Carroll
P2860
P304
P356
10.1517/14712598.2011.554810
P407
P577
2011-01-27T00:00:00Z